US Patent 10111939 Albumin-free botulinum toxin formulations
Patent 10111939 was granted and assigned to Revance Therapeutics, Inc. on October, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10111939 Albumin-free botulinum toxin formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.